Solid-Phase mRNA Production Platform
mRNA vaccine/therapeutic production technology
Pre-clinical (Technology Development)Active
Key Facts
Indication
mRNA vaccine/therapeutic production technology
Phase
Pre-clinical (Technology Development)
Status
Active
Company
About Affinity Molecules
Affinity Molecules is a private, revenue-generating biotech services company providing critical R&D and pre-clinical development support to the biologics industry. Its core expertise lies in creating manufacturing-grade CHO cell lines for biologics production, alongside a suite of protein expression, purification, and assay development services. A recent NIH Phase I SBIR grant for a novel mRNA vaccine production platform indicates an expansion into proprietary technology development. The company operates primarily as a CRO/CDMO-like service provider, catering to academic, biotech, and pharmaceutical clients.
View full company profile